Global Head & Neck Cancer Drugs Market

Global Head & Neck Cancer Drugs Market
Report Id
PH-CF423BF
Publishing Date
September 2019
Number of Pages
156
Available Formats
Global Head & Neck Cancer Drugs Market

360iResearch predicts the Global Head & Neck Cancer Drugs Market to grow from USD xx.xx Millions in 2018 to USD xx.xx Millions by 2025, at a Compound Annual Growth Rate (CAGR) of xx.xx%. The year 2018 has been considered as the base year, while the forecast period is up to 2025.

Scope of the Report:

AttributeDetails
Base Year for Estimation2018
Historical Period2016 - 2017
Estimation Period2019 - 2020
Forecast Year2025
Market RepresentationRevenue in USD Million
Report CoverageRevenue Forecast, Company Share, Competitive Landscape, and Industry Trends.
Customization ScopeIf you need specific market information, which is not currently within the scope of the report, we will provide it to you as a part of customization. We offer 20% free customization which is equivalent to 5 analysts working days.

Company Usability Profiles:

The Global Head & Neck Cancer Drugs Market research report provides the company usability profiles and analyze the business overview, strategy, and SWOT analysis of the following company:

  • AstraZeneca Plc.
  • Bristol-Myers Squibb Company
  • Celgene Corporation
  • Eli Lilly and Company
  • Eli Lilly and Company Limited
  • F. Hoffmann-La Roche Ltd.
  • Fresenius Medical Care AG & Co. KGaA
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Novartis
  • Pfizer Inc.
  • Roche Holding AG
  • Sanofi
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Limited

Market Segmentation & Coverage:

The research report categorizes the Global Head & Neck Cancer Drugs Market to forecast the revenues and analyze the trends in each of the following segments:

  • GLOBAL HEAD & NECK CANCER DRUGS MARKET, BY DRUG CLASS
    • Chemotherapy
    • Immunotherapy
    • Radiation therapy
    • Surgery
    • Targeted Therapy
  • GLOBAL HEAD & NECK CANCER DRUGS MARKET, BY PRODUCT
    • Bleomycin
    • Cetuximab
    • Docetaxel
    • Erbitux (Cetuximab)
    • Hydrea (Hydroxyurea)
    • Hydroxyurea
    • Keytruda (Pembrolizumab)
    • Methotrexate
    • Nivolumab
    • Opdivo (Nivolumab)
    • Pembrolizumab
    • Taxotere (Docetaxel)
    • Trexall (Methotrexate)
  • GLOBAL HEAD & NECK CANCER DRUGS MARKET, BY END USER
    • Cancer Research Institutes
    • Clinics
    • Hospitals
  • GLOBAL HEAD & NECK CANCER DRUGS MARKET, BY GEOGRAPHY
    • Americas
      • Canada
      • Mexico
      • United States
    • Asia-Pacific
      • China
      • India
      • Japan
    • Europe, Middle East & Africa
      • France
      • Germany
      • United Kingdom

Report Highlights:

The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights on the factors that are driving and restraining the demand of the Global Head & Neck Cancer Drugs Market. Moreover, the study highlights current market trends and provides forecast. We also have highlighted future trends in the Global Head & Neck Cancer Drugs Market that will impact the demand during the forecast period. Moreover, the competitive analysis of the Global Head & Neck Cancer Drugs Market brings an insight on the company usability profiles of the leading players. Additionally, the analysis highlights business overview, strategy, and SWOT analysis of the key companies in the market.

Reasons to Buy:

The Global Head & Neck Cancer Drugs Market research study reveals hidden insights and dynamic, which in turn helps the players in the ecosystem take better strategic decisions. The firms looking for purchasing the Global Head & Neck Cancer Drugs Market research report could look for following prospects on their way to better understand the market that can aid further decision making and possibly identify the best opportunities to exploit.

  • Evaluate the qualitative and quantitative aspects of the report and analyze the Global Head & Neck Cancer Drugs Market penetration with respect to industries and geographies.
  • Evaluates the key vendors and deeply analyze competitive landscape, revenue pockets, market trends, growth prospects, pain points, drivers, restraints, challenges and opportunities of the Global Head & Neck Cancer Drugs Market .
  • Evaluate the key vendors in the Global Head & Neck Cancer Drugs Market in terms of products satisfaction and business strategy. This helps identify consumer preferences and understand its current position in 360iResearch FPNV Positioning Matrix.
  1. Preface
    1. Objectives of the Study
    2. Market Segmentation & Coverage
    3. Years Considered for the Study
    4. Currency & Pricing
    5. Language
    6. Stakeholders
  2. Research & Forecasting
    1. Research Methodology
      1. Research Process
      2. Research Framework
      3. Research Reliability & Validity
      4. Research Assumptions
    2. Forecasting Methodology
    3. Research Outcome
      1. 360iResearch Competitive Strategic Window
        1. Leverage Zone
        2. Vantage Zone
        3. Speculative Zone
        4. Bottleneck Zone
      2. 360iResearch FPNV Positioning Matrix
        1. 360iResearch Quadrants
          1. Forefront
          2. Pathfinders
          3. Niche
          4. Vital
        2. Business Strategy
          1. Business Growth
          2. Industry Coverage
          3. Financial Viability
          4. Channel Support
        3. Product Satisfaction
          1. Value for Money
          2. Ease of Use
          3. Product Features
          4. Customer Support
  3. Executive Summary
    1. Outlook in the Head & Neck Cancer Drugs Market
    2. Opportunities in the Head & Neck Cancer Drugs Market
    3. Geographical Analysis in the Head & Neck Cancer Drugs Market
  4. Premium Insight
    1. Market Connectivity
    2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunities
      4. Challenges
    3. Porter’s Five Forces Analysis
      1. Threat of New Entrants
      2. Threat of Substitutes
      3. Bargaining Power of Customers
      4. Bargaining Power of Suppliers
      5. Industry Rivalry
    4. Industry Trends
  5. Global Head & Neck Cancer Drugs Market, by Drug Class
    1. Overview
    2. Market Sizing & Forecasting
    3. Chemotherapy
    4. Immunotherapy
    5. Radiation therapy
    6. Surgery
    7. Targeted Therapy
  6. Global Head & Neck Cancer Drugs Market, by Product
    1. Overview
    2. Market Sizing & Forecasting
    3. Bleomycin
    4. Cetuximab
    5. Docetaxel
    6. Erbitux (Cetuximab)
    7. Hydrea (Hydroxyurea)
    8. Hydroxyurea
    9. Keytruda (Pembrolizumab)
    10. Methotrexate
    11. Nivolumab
    12. Opdivo (Nivolumab)
    13. Pembrolizumab
    14. Taxotere (Docetaxel)
    15. Trexall (Methotrexate)
  7. Global Head & Neck Cancer Drugs Market, by End User
    1. Overview
    2. Market Sizing & Forecasting
    3. Cancer Research Institutes
    4. Clinics
    5. Hospitals
  8. Global Head & Neck Cancer Drugs Market, by Geography
    1. Americas
      1. Overview
      2. Market Sizing & Forecasting
      3. Canada
      4. Mexico
      5. United States
    2. Asia-Pacific
      1. Overview
      2. Market Sizing & Forecasting
      3. China
      4. India
      5. Japan
    3. Europe, Middle East & Africa
      1. Overview
      2. Market Sizing & Forecasting
      3. France
      4. Germany
      5. United Kingdom
  9. Competitive Landscape
    1. 360iResearch FPNV Positioning Matrix for Global Head & Neck Cancer Drugs Market
    2. Market Vendor Ranking Analysis for Global Head & Neck Cancer Drugs Market
    3. Competitive News Feed Analysis for Global Head & Neck Cancer Drugs Market
  10. Company Usability Profiles
    1. AstraZeneca Plc.
      1. Overview
      2. Strategy
      3. SWOT
      4. Scorecard
    2. Bristol-Myers Squibb Company
      1. Overview
      2. Strategy
      3. SWOT
      4. Scorecard
    3. Celgene Corporation
      1. Overview
      2. Strategy
      3. SWOT
      4. Scorecard
    4. Eli Lilly and Company
      1. Overview
      2. Strategy
      3. SWOT
      4. Scorecard
    5. Eli Lilly and Company Limited
      1. Overview
      2. Strategy
      3. SWOT
      4. Scorecard
    6. F. Hoffmann-La Roche Ltd.
      1. Overview
      2. Strategy
      3. SWOT
      4. Scorecard
    7. Fresenius Medical Care AG & Co. KGaA
      1. Overview
      2. Strategy
      3. SWOT
      4. Scorecard
    8. Johnson & Johnson
      1. Overview
      2. Strategy
      3. SWOT
      4. Scorecard
    9. Merck & Co., Inc.
      1. Overview
      2. Strategy
      3. SWOT
      4. Scorecard
    10. Novartis
      1. Overview
      2. Strategy
      3. SWOT
      4. Scorecard
    11. Pfizer Inc.
      1. Overview
      2. Strategy
      3. SWOT
      4. Scorecard
    12. Roche Holding AG
      1. Overview
      2. Strategy
      3. SWOT
      4. Scorecard
    13. Sanofi
      1. Overview
      2. Strategy
      3. SWOT
      4. Scorecard
    14. Sun Pharmaceutical Industries Ltd.
      1. Overview
      2. Strategy
      3. SWOT
      4. Scorecard
    15. Teva Pharmaceutical Industries Limited
      1. Overview
      2. Strategy
      3. SWOT
      4. Scorecard
  11. Appendix
    1. Discussion Guide
    2. Top Reports
      1. Global Automated Fingerprint Identification System Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
      2. Global Varicose Vein Treatment Devices Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
      3. Global Autonomous Truck Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
      4. Global Energy Security Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
    3. Author Details

List of Tables

  1. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, 2017-2025 (USD MILLIONS)
  2. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLIONS)
  3. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLIONS)
  4. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY CHEMOTHERAPY, BY GEOGRAPHY, 2017-2025 (USD MILLIONS)
  5. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY IMMUNOTHERAPY, BY GEOGRAPHY, 2017-2025 (USD MILLIONS)
  6. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY RADIATION THERAPY, BY GEOGRAPHY, 2017-2025 (USD MILLIONS)
  7. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY SURGERY, BY GEOGRAPHY, 2017-2025 (USD MILLIONS)
  8. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY TARGETED THERAPY, BY GEOGRAPHY, 2017-2025 (USD MILLIONS)
  9. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLIONS)
  10. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY BLEOMYCIN, BY GEOGRAPHY, 2017-2025 (USD MILLIONS)
  11. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY CETUXIMAB, BY GEOGRAPHY, 2017-2025 (USD MILLIONS)
  12. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY DOCETAXEL, BY GEOGRAPHY, 2017-2025 (USD MILLIONS)
  13. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY ERBITUX (CETUXIMAB), BY GEOGRAPHY, 2017-2025 (USD MILLIONS)
  14. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY HYDREA (HYDROXYUREA), BY GEOGRAPHY, 2017-2025 (USD MILLIONS)
  15. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY HYDROXYUREA, BY GEOGRAPHY, 2017-2025 (USD MILLIONS)
  16. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY KEYTRUDA (PEMBROLIZUMAB), BY GEOGRAPHY, 2017-2025 (USD MILLIONS)
  17. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY METHOTREXATE, BY GEOGRAPHY, 2017-2025 (USD MILLIONS)
  18. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY NIVOLUMAB, BY GEOGRAPHY, 2017-2025 (USD MILLIONS)
  19. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY OPDIVO (NIVOLUMAB), BY GEOGRAPHY, 2017-2025 (USD MILLIONS)
  20. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY PEMBROLIZUMAB, BY GEOGRAPHY, 2017-2025 (USD MILLIONS)
  21. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY TAXOTERE (DOCETAXEL), BY GEOGRAPHY, 2017-2025 (USD MILLIONS)
  22. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY TREXALL (METHOTREXATE), BY GEOGRAPHY, 2017-2025 (USD MILLIONS)
  23. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2017-2025 (USD MILLIONS)
  24. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY CANCER RESEARCH INSTITUTES, BY GEOGRAPHY, 2017-2025 (USD MILLIONS)
  25. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY CLINICS, BY GEOGRAPHY, 2017-2025 (USD MILLIONS)
  26. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY HOSPITALS, BY GEOGRAPHY, 2017-2025 (USD MILLIONS)
  27. AMERICAS HEAD & NECK CANCER DRUGS MARKET SIZE, BY COUNTRY, 2017-2025 (USD MILLIONS)
  28. AMERICAS HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLIONS)
  29. AMERICAS HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLIONS)
  30. AMERICAS HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2017-2025 (USD MILLIONS)
  31. ASIA-PACIFIC HEAD & NECK CANCER DRUGS MARKET SIZE, BY COUNTRY, 2017-2025 (USD MILLIONS)
  32. ASIA-PACIFIC HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLIONS)
  33. ASIA-PACIFIC HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLIONS)
  34. ASIA-PACIFIC HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2017-2025 (USD MILLIONS)
  35. EUROPE, MIDDLE EAST & AFRICA HEAD & NECK CANCER DRUGS MARKET SIZE, BY COUNTRY, 2017-2025 (USD MILLIONS)
  36. EUROPE, MIDDLE EAST & AFRICA HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLIONS)
  37. EUROPE, MIDDLE EAST & AFRICA HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLIONS)
  38. EUROPE, MIDDLE EAST & AFRICA HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2017-2025 (USD MILLIONS)
  39. GLOBAL HEAD & NECK CANCER DRUGS MARKET: MARKET VENDOR RANKING ANALYSIS
  40. ASTRAZENECA PLC.: FPNV SCORECARD
  41. ASTRAZENECA PLC.: BUSINESS STRATEGY
  42. ASTRAZENECA PLC.: PRODUCT SATISFACTION
  43. BRISTOL-MYERS SQUIBB COMPANY: FPNV SCORECARD
  44. BRISTOL-MYERS SQUIBB COMPANY: BUSINESS STRATEGY
  45. BRISTOL-MYERS SQUIBB COMPANY: PRODUCT SATISFACTION
  46. CELGENE CORPORATION: FPNV SCORECARD
  47. CELGENE CORPORATION: BUSINESS STRATEGY
  48. CELGENE CORPORATION: PRODUCT SATISFACTION
  49. ELI LILLY AND COMPANY: FPNV SCORECARD
  50. ELI LILLY AND COMPANY: BUSINESS STRATEGY
  51. ELI LILLY AND COMPANY: PRODUCT SATISFACTION
  52. ELI LILLY AND COMPANY LIMITED: FPNV SCORECARD
  53. ELI LILLY AND COMPANY LIMITED: BUSINESS STRATEGY
  54. ELI LILLY AND COMPANY LIMITED: PRODUCT SATISFACTION
  55. F. HOFFMANN-LA ROCHE LTD.: FPNV SCORECARD
  56. F. HOFFMANN-LA ROCHE LTD.: BUSINESS STRATEGY
  57. F. HOFFMANN-LA ROCHE LTD.: PRODUCT SATISFACTION
  58. FRESENIUS MEDICAL CARE AG & CO. KGAA: FPNV SCORECARD
  59. FRESENIUS MEDICAL CARE AG & CO. KGAA: BUSINESS STRATEGY
  60. FRESENIUS MEDICAL CARE AG & CO. KGAA: PRODUCT SATISFACTION
  61. JOHNSON & JOHNSON: FPNV SCORECARD
  62. JOHNSON & JOHNSON: BUSINESS STRATEGY
  63. JOHNSON & JOHNSON: PRODUCT SATISFACTION
  64. MERCK & CO., INC.: FPNV SCORECARD
  65. MERCK & CO., INC.: BUSINESS STRATEGY
  66. MERCK & CO., INC.: PRODUCT SATISFACTION
  67. NOVARTIS: FPNV SCORECARD
  68. NOVARTIS: BUSINESS STRATEGY
  69. NOVARTIS: PRODUCT SATISFACTION
  70. PFIZER INC.: FPNV SCORECARD
  71. PFIZER INC.: BUSINESS STRATEGY
  72. PFIZER INC.: PRODUCT SATISFACTION
  73. ROCHE HOLDING AG: FPNV SCORECARD
  74. ROCHE HOLDING AG: BUSINESS STRATEGY
  75. ROCHE HOLDING AG: PRODUCT SATISFACTION
  76. SANOFI: FPNV SCORECARD
  77. SANOFI: BUSINESS STRATEGY
  78. SANOFI: PRODUCT SATISFACTION
  79. SUN PHARMACEUTICAL INDUSTRIES LTD.: FPNV SCORECARD
  80. SUN PHARMACEUTICAL INDUSTRIES LTD.: BUSINESS STRATEGY
  81. SUN PHARMACEUTICAL INDUSTRIES LTD.: PRODUCT SATISFACTION
  82. TEVA PHARMACEUTICAL INDUSTRIES LIMITED: FPNV SCORECARD
  83. TEVA PHARMACEUTICAL INDUSTRIES LIMITED: BUSINESS STRATEGY
  84. TEVA PHARMACEUTICAL INDUSTRIES LIMITED: PRODUCT SATISFACTION
  85. GLOBAL HEAD & NECK CANCER DRUGS MARKET: AUTHOR DETAILS

List of Figures

  1. Global Head & Neck Cancer Drugs Market: Research Process
  2. Global Head & Neck Cancer Drugs Market: Research Framework
  3. Global Head & Neck Cancer Drugs Market: Forecasting Methodology
  4. Global Head & Neck Cancer Drugs Market: 360iResearch Competitive Strategic Window
  5. Global Head & Neck Cancer Drugs Market: 360iResearch FPNV Positioning Matrix
  6. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, 2017-2025 (USD MILLIONS)
  7. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY GEOGRAPHY, 2025 (USD MILLIONS)
  8. GLOBAL HEAD & NECK CANCER DRUGS MARKET: MARKET CONNECTIVITY
  9. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2018 VS 2025 (USD MILLIONS)
  10. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY DRUG CLASS, 2025 (USD MILLIONS)
  11. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2018 VS 2025 (USD MILLIONS)
  12. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY PRODUCT, 2025 (USD MILLIONS)
  13. GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2018 VS 2025 (USD MILLIONS)
  14. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HEAD & NECK CANCER DRUGS MARKET SIZE, BY END USER, 2025 (USD MILLIONS)
  15. ASTRAZENECA PLC.: BUSINESS SWOT
  16. BRISTOL-MYERS SQUIBB COMPANY: BUSINESS SWOT
  17. CELGENE CORPORATION: BUSINESS SWOT
  18. ELI LILLY AND COMPANY: BUSINESS SWOT
  19. ELI LILLY AND COMPANY LIMITED: BUSINESS SWOT
  20. F. HOFFMANN-LA ROCHE LTD.: BUSINESS SWOT
  21. FRESENIUS MEDICAL CARE AG & CO. KGAA: BUSINESS SWOT
  22. JOHNSON & JOHNSON: BUSINESS SWOT
  23. MERCK & CO., INC.: BUSINESS SWOT
  24. NOVARTIS: BUSINESS SWOT
  25. PFIZER INC.: BUSINESS SWOT
  26. ROCHE HOLDING AG: BUSINESS SWOT
  27. SANOFI: BUSINESS SWOT
  28. SUN PHARMACEUTICAL INDUSTRIES LTD.: BUSINESS SWOT
  29. TEVA PHARMACEUTICAL INDUSTRIES LIMITED: BUSINESS SWOT

To request a free sample copy of this report, please complete the form below.

We value your investment and offer free customization with every report to fulfil your exact research needs.
This website is secure and your personal details are safe. Privacy Policy
Payment Card Industry Data Security StandardGeneral Data Protection Regulation